Staging and prognostic factors in nonseminomatous testicular cancer

P. Murphy, D. H. Johnson

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Staging of nonseminomatous testicular cancers, as with other tumors, renders important prognostic information and is necessary for making appropriate treatment recommendations. There is no universally accepted staging system for testis cancer, however. Despite the lack of uniformity, most of the staging systems in use today are capable of segregating patients into a 'good-risk' or 'poor-risk' category. The former group experiences cure less frequently and are appropriate candidates for investigational treatment. Tumor bulk is the most important prognostic factor in virtually all staging systems.

Original languageEnglish (US)
Pages (from-to)1233-1243
Number of pages11
JournalHematology/Oncology Clinics of North America
Volume5
Issue number6
StatePublished - 1991

Fingerprint

Testicular Neoplasms
Investigational Therapies
Neoplasms
Therapeutics

ASJC Scopus subject areas

  • Hematology
  • Oncology

Cite this

Staging and prognostic factors in nonseminomatous testicular cancer. / Murphy, P.; Johnson, D. H.

In: Hematology/Oncology Clinics of North America, Vol. 5, No. 6, 1991, p. 1233-1243.

Research output: Contribution to journalArticle

@article{ba6bfbff98654f2aa2c28b9d3b1ecffe,
title = "Staging and prognostic factors in nonseminomatous testicular cancer",
abstract = "Staging of nonseminomatous testicular cancers, as with other tumors, renders important prognostic information and is necessary for making appropriate treatment recommendations. There is no universally accepted staging system for testis cancer, however. Despite the lack of uniformity, most of the staging systems in use today are capable of segregating patients into a 'good-risk' or 'poor-risk' category. The former group experiences cure less frequently and are appropriate candidates for investigational treatment. Tumor bulk is the most important prognostic factor in virtually all staging systems.",
author = "P. Murphy and Johnson, {D. H.}",
year = "1991",
language = "English (US)",
volume = "5",
pages = "1233--1243",
journal = "Hematology/Oncology Clinics of North America",
issn = "0889-8588",
publisher = "W.B. Saunders Ltd",
number = "6",

}

TY - JOUR

T1 - Staging and prognostic factors in nonseminomatous testicular cancer

AU - Murphy, P.

AU - Johnson, D. H.

PY - 1991

Y1 - 1991

N2 - Staging of nonseminomatous testicular cancers, as with other tumors, renders important prognostic information and is necessary for making appropriate treatment recommendations. There is no universally accepted staging system for testis cancer, however. Despite the lack of uniformity, most of the staging systems in use today are capable of segregating patients into a 'good-risk' or 'poor-risk' category. The former group experiences cure less frequently and are appropriate candidates for investigational treatment. Tumor bulk is the most important prognostic factor in virtually all staging systems.

AB - Staging of nonseminomatous testicular cancers, as with other tumors, renders important prognostic information and is necessary for making appropriate treatment recommendations. There is no universally accepted staging system for testis cancer, however. Despite the lack of uniformity, most of the staging systems in use today are capable of segregating patients into a 'good-risk' or 'poor-risk' category. The former group experiences cure less frequently and are appropriate candidates for investigational treatment. Tumor bulk is the most important prognostic factor in virtually all staging systems.

UR - http://www.scopus.com/inward/record.url?scp=0025841895&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025841895&partnerID=8YFLogxK

M3 - Article

VL - 5

SP - 1233

EP - 1243

JO - Hematology/Oncology Clinics of North America

JF - Hematology/Oncology Clinics of North America

SN - 0889-8588

IS - 6

ER -